← Back to patent-cliff list
CAS 1430052-97-3
(2R,3S)-5-(Oxiran-2-ylmethoxy)-1,2,3,4-tetrahydronaphthalene-2,3-diol
Codes: Nadolol-007
Application context (from source-drug indications)
Diabetic macular oedemaNadololDiabetic retinopathyNadolol感染性角结膜炎NadololDry eye syndromeNadololHypertensionNadololHyperthyroidismNadolol
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Nadolol | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
5,8-Dihydro-1-naphthol→alpha-Naphthyl acetate→cis-6,7-Dihydroxy-5,6,7,8-tetrahydronaphthalen-1-yl acetate→(6R,7S)-5,6,7,8-Tetrahydronaphthalene-1,6,7-triol→Sodium cis-6,7-dihydroxy-5,6,7,8-tetrahydronaphthalen-1-olate→(+/-)-2-(Chloromethyl)oxirane→(2R,3S)-5-(Oxiran-2-ylmethoxy)-1,2,3,4-tetrahydronaphthalene-2,3-diol→2-Methylpropan-2-amine
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.